Investor Relations Home

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports Fourth Quarter 2017 Financial Results
	2017 Form 10K
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

More >>

There are currently no events to display.

Recent News

RSS Feeds | More >>

05/19/09

Summary Toggle New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease Study Presented at the American Thoracic Society by Researchers at The Children's Hospital of Philadelphia Confirms Accuracy and Clinical Value of Noninvasive SpCO(R) and SpMet(R) IRVINE, Calif ., May 19 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measu
05/13/09

Summary Toggle New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children -- Study Presented at the Pediatric Academic Societies Annual Meeting by Vanderbilt University Researchers Shows a Statistically-Significant Association between SpCO and Measures of Lung Function -- IRVINE, Calif., May 13 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oxim
05/12/09

Summary Toggle Masimo to Present at the Deutsche Bank 34th Annual Health Care Conference IRVINE, Calif ., May 12 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that its management is scheduled to present at the Deutsche Bank 34th Annual Health Care Conference
05/05/09

Summary Toggle Masimo Reports First Quarter 2009 Financial Results Q1 2009 Highlights: Earnings per share increased by 47% to $0.22 per share from $0.15 in prior year Product revenues increased approximately 25% to $74.5 million from $59.7 million in prior year IRVINE, Calif ., May 5 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse
04/28/09

Summary Toggle FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List --Citing Need for Early and Accurate Carbon Monoxide Exposure Detection Following Disasters, Agency Unanimously Approves and Authorizes Funds to Purchase Rad-57s IRVINE, Calif., April 28, 2009 /PRNewswire-FirstCall via COMTEX/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measu
04/16/09

Summary Toggle Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM)) Hospital-wide Implementation of Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Could Generate Nearly $500,000 in Net Annual Cost Savings and Financial Gains IRVINE, Calif ., April 16 , Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximet
04/14/09

Summary Toggle Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 Conference call and webcast to begin after markets close at 2:00 p.m. PT ( 5:00 p.m.
03/31/09

Summary Toggle New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICU IRVINE, Calif., March 31, 2009 /PRNewswire via COMTEX/ -- First Study to Expand PVI Utility Beyond the OR Presented at the 29th International Symposium on Intensive Care and Emergency Medicine in Brussels IRVINE, Calif., March 31 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse
03/24/09

Summary Toggle Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor --Success in Limited Market Release Hospitals Highlights Early Clinical Benefits and Patient Impact IRVINE, Calif., March 24, 2009 /PRNewswire-FirstCall via COMTEX/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced
03/16/09

Summary Toggle New Clinical Study Finds Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Accurate in the Noninvasive Monitoring of Fluid Status During Surgery --UCSF Researchers Presented Study Data Demonstrating the Unique Ability of Masimo PVI(TM) to Reflect Acute Changes in Intravascular Fluid Volume at the International Anesthesia Research Society 83rd Scientific Congress March 16, 2009 /PRNewswire-FirstCall via COMTEX/ -- Masimo (Nasdaq: MASI), the i

Receive E-mail Alerts

To request a copy of the Annual Report, click here .

Investor Relations Home

Q1 2018 Masimo Corporation Earnings Conference Call

Masimo at the Barclays Global Healthcare Conference

Stock Quote

Online Investor Kit

Supplemental Financial Information

Corporate Profile

Upcoming Events

Recent News